- NLM Classification (117)
- WD Disorders of systemic, metabolic or environmental origin (22)
- WD 300-375 Immunologic and collagen diseases (6)
- WD Disorders of systemic, metabolic or environmental origin (22)
Götz, G. and Hawlik, K. (2020): Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS. Update 2020. Decision Support Document 106/ Update 2020.
Hawlik, K. and Wild, C. (2017): Extracorporeal cytokine haemadsorption in patients with sepsis or SIRS. Decision Support Document 106.
Hintringer, K. and Wild, C. (2009): Bioresonance for allergiges, atopic dermatitis, non-organic gastrointestinal complaints, pain and rheumatic diseases. Decision Support Document 31.
Korencan, A. (2007): [Diagnosis of cytomegalovirus disease in immunocompromised patients]. HTA-Newsletter 53: p. 4.
Wild, C. (2005): [Provocation-neutralisation therapy for food allergy]. HTA-Newsletter 34: p. 4.
Wild, C. (2003): [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]. HTA-Newsletter 21: pp. 2-3.